PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism.
Sun M, Li L, Niu Y, Wang Y, Yan Q, Xie F, Qiao Y, Song J, Sun H, Li Z, Lai S, Chang H, Zhang H, Wang J, Yang C, Zhao H, Tan J, Li Y, Liu S, Lu B, Liu M, Kong G, Zhao Y, Zhang C, Lin SH, Luo C, Zhang S, Shan C.
Sun M, et al. Among authors: chang h.
Acta Pharm Sin B. 2023 Jan;13(1):157-173. doi: 10.1016/j.apsb.2022.05.019. Epub 2022 May 25.
Acta Pharm Sin B. 2023.
PMID: 36815049
Free PMC article.